Search

Compliance to oral bisphosphonate therapy similar regardless of follow-up type

Osteoporos Int. 2014 Apr;25(4):1345-55. doi: 10.1007/s00198-013-2610-4. Epub 2014 Jan 21.

RCT Trauma Falls Osteoporosis Fracture Alendronate Risedronate Calcium Oral Bisphosphonate Therapy Prevention Program Supplements Vitamin - Hide

Read Ace Report

Denosumab increases BMD and reduces bone turnover vs monthly oral bisphosphonate

Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28.

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Fracture Amgen Risedronate Denosumab Bisphosphonate Ibandronate Oral - Hide

Read Ace Report

WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Axial Skeleton Spine Spine Lumbar Lower Extremity Hip Bone Femur Neck Amgen Denosumab Oral ZOL Zoledronic Acid - Hide

Read Ace Report

Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level

J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y

RCT Metabolic Disorders Osteoporosis Bone Radius Fracture Alendronate Oral - Hide

Read Ace Report

Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates

J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Amgen Denosumab Intravenous Injection Oral Subcutaneous Injections ZOL Zoledronic Acid - Hide

Read Ace Report

WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Axial Skeleton Spine Spine Lumbar Lower Extremity Hip Bone Femur Neck Amgen Bisphosphonate Subcutaneous Romosozumab Subcutaneous Teriparatide - Hide

Read Ace Report

Timing of bisphosphonate administration does not affect fracture healing or complications

J Bone Joint Surg Br. 2012 Jul;94(7):956-60

RCT Trauma Osteoporosis Intertrochanteric Fracture Risedronate Oral Bisphosphonate - Hide

Read Ace Report

Bone mineral density loss following total joint arthroplasty mitigated by bisphosphonate therapy

Osteoporos Int. 2018 Jul;29(7):1525-1537. doi: 10.1007/s00198-018-4488-7

Meta-analysis Arthroplasty Lower Extremity Hip Knee Alendronate Zoledronate Clodronate Bisphosphonate Control Pamidronate Preservation Prosthesis Replacement THA TKA - Hide

Read Ace Report

Oral ibandronic acid inferior to IV zoledronic acid for metastatic breast cancer to bone

Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4.

RCT Tumour Breast Metastasis Roche Ibandronic Acid Intravenous Zoledronic Acid IV Oral - Hide

Read Ace Report

COA 2015: Patients more satisfied with oral aspirin for post TKA DVT vs. injected therapy

RCT Arthroplasty Lower Extremity Knee Injected Low Molecular Weight Heparin Oral Aspirin Prophylaxis TKA - Hide

Read Ace Report

Early bisphosphonate use after surgery does not appear to delay fracture healing

Osteoporos Int. 2015 Feb;26(2):431-41.

Meta-analysis Metabolic Disorders Fracture Bisphosphonate Control Delayed Impact Negative Placebo - Hide

Read Ace Report

Bisphosphonates effective in osteoporotic males in terms of fracture, BMD, and biomarkers

Osteoporos Int. 2015 Sep;26(9):2355-63.

Meta-analysis Metabolic Disorders Osteoporosis Fracture Alendronate Risedronate Zoledronate Bisphosphonate Control Ibandronate Intravenously Oral Placebo Serum - Hide

Read Ace Report

Early Bisphosphonate Therapy on Time to Fracture Healing in Proximal Femur Fixation

ANZ J Surg. 2022 01-Jun;():. 10.1111/ans.17792

Meta-analysis General Orthopaedics Appendicular Lower Extremity Lower Extremity Bone Femur Fracture Bisphosphonate Control - Hide

Read Ace Report

Topical drug-free therapy more effective than oral NSAID ketoprofen for muscle soreness

J Sports Sci. 2016 Jan;34(1):88-95.

RCT Sports Medicine Pain IDEA AG Drug-Free Exercise Gel NSAID Oral Topical Ketoprofen Transfersome - Hide

Read Ace Report

Improved bone mineral density up to 12 months with a 6-month oral alendronate intervention

J Bone Joint Surg Am. 2006 Feb;88(2):267-72

RCT Arthroplasty Osteoarthritis Women Lower Extremity Knee Arthritis Oral Alendronate - Hide

Read Ace Report

Oral alendronate cannot yet be recommended for children with OI

J Clin Endocrinol Metab. 2011 Feb;96(2):355-64

RCT Pediatric Orthopaedics Adolescent Children Osteogenesis Merck Oral Alendronate Placebo - Hide

Read Ace Report

AAOS 2016: Oral antibiotics correlated with fewer re-infections after two-stage TJA

RCT Arthroplasty Infection TJA Antibiotic Therapy Oral Antibiotics - Hide

Read Ace Report

Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy

J Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7

Meta-analysis Metabolic Disorders Lower Extremity Hip Arthroplasty Bisphosphonate Preventing - Hide

Read Ace Report

Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients

Osteoporos Int. 2016 Jan;27(1):295-9

Meta-analysis Metabolic Disorders Bone Femur Head Alendronate Zoledronate Arthroplasty Bisphosphonate Control Placebo Preventing THA - Hide

Read Ace Report

Three-month course of oral antibiotics reduces PJI rate after two-stage revision

Clin Orthop Relat Res. 2017 Jan;475(1):56-61

RCT Arthroplasty Infection Lower Extremity Hip Knee Oral Antibiotics Revision - Hide

Date Range

Report Types

Condition

See all (83)

Region of the Body

See all (22)

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

Compliance to oral bisphosphonate therapy similar regardless of follow-up type

Denosumab increases BMD and reduces bone turnover vs monthly oral bisphosphonate

WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy

Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level

Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates

WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide

Timing of bisphosphonate administration does not affect fracture healing or complications

Bone mineral density loss following total joint arthroplasty mitigated by bisphosphonate therapy

Oral ibandronic acid inferior to IV zoledronic acid for metastatic breast cancer to bone

COA 2015: Patients more satisfied with oral aspirin for post TKA DVT vs. injected therapy

Early bisphosphonate use after surgery does not appear to delay fracture healing

Bisphosphonates effective in osteoporotic males in terms of fracture, BMD, and biomarkers

Early Bisphosphonate Therapy on Time to Fracture Healing in Proximal Femur Fixation

Topical drug-free therapy more effective than oral NSAID ketoprofen for muscle soreness

Improved bone mineral density up to 12 months with a 6-month oral alendronate intervention

Oral alendronate cannot yet be recommended for children with OI

AAOS 2016: Oral antibiotics correlated with fewer re-infections after two-stage TJA

Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy

Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients

Three-month course of oral antibiotics reduces PJI rate after two-stage revision

Author Interviews

Conference Reports

PeerView

All Videos (144 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

My Favorites

My Specialties

Newsletter

Account Settings & Billing

Logout

Date Range

Report Types

Condition

See all (83)

Region of the Body

See all (22)

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

Please be patient while we setup your OrthoEvidence account.

All Videos
(144 Videos)

Please be patient
while we setup your
OrthoEvidence account.